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C n F 2n-1 SO 3 -n=7-14 (multiple isomers e.g. , )
≥4 & ≥18 C 4 F 7 -C 14 F 27 [31, 40, 42, 43] ether-PFSAs C n F 2n+1 SO 4 -n=4-12 (multiple isomers e.g. );
C n F 2n+1 SO 4 -n=6-9 (multiple isomers e.g. )
C n F 2n+1 SO 5 -n=6-12 (multiple isomers e.g. ); n = 2-9
H-substituted-unsaturatedPFSAs n = 1-6 (multiple isomers possible); n:2 FT thioethers n = 2-5; n = 2-6; n = 2-5; n = 2-6; n = 1-7; n = 2-7; n = 3-5;
n =3-5
8 & 37 C 8 F 9 -C 25 F 29 [29-31, 40, 48] n:2 FT sulfoxides n = 2-5; n = 3; n = 3, 4
3 & 7 C 14 F 13 -C 16 F 17 [30, 40] n:2 FT sulfones n = 2-4; n = 2-4 2 & 6 C 9 F 9 -C 17 F 17 [31] n:2 FT sulfonamides n = 3-6; n = 2-8;
3 & 12 C 13 F 9 -C 25 F 33 [29] [30] [31] FT betaines X = H, n = 2-6; X = F, n = 2-7;
4 & 17 C 12 F 9 -C 22 F 32 [29] [30] [31] M A N U S C R I P T 1 & 4 C 6 F 7 -C 9 F 13 [31] amine-PFSMs n = 3-8; n = 5, 6; n = 4-6; n = 3-8;
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ammonio-PFSMs n = 3-8; n = 2-8; n = 3-6; n = 4-9; n = 2-8; n = 4-6; n = 2-8; n = 4-6; n = 3-6; n = 2-8; n = 4-6; n = 2-6; n = 3-6,14,16; n = 3-6; n = 4-6; n = 3-6; n = 5, 6; n = 3-6; n = 3-8; n = 3-9; n = 4-6; n = 3-6; n = 3-6; n = 3-6;
27 & ≥124 C 9 F 7 -C 25 F 33 [29-32, 36, 40] M A N U S C R I P T A C C E P T E D n = 3-6; n = 3-8; n = 2-6 Perfluoroalkyl and polyfluoroalkyl phosphates (PFAPs) 
